300 related articles for article (PubMed ID: 16988792)
1. Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial.
Wissel J; Haydn T; Müller J; Brenneis C; Berger T; Poewe W; Schelosky LD
J Neurol; 2006 Oct; 253(10):1337-41. PubMed ID: 16988792
[TBL] [Abstract][Full Text] [Related]
2. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
[TBL] [Abstract][Full Text] [Related]
3. [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].
Pinsger M; Schimetta W; Volc D; Hiermann E; Riederer F; Pölz W
Wien Klin Wochenschr; 2006 Jun; 118(11-12):327-35. PubMed ID: 16855921
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Riva N; Mora G; Sorarù G; Lunetta C; Ferraro OE; Falzone Y; Leocani L; Fazio R; Comola M; Comi G;
Lancet Neurol; 2019 Feb; 18(2):155-164. PubMed ID: 30554828
[TBL] [Abstract][Full Text] [Related]
5. Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial.
Turcotte D; Doupe M; Torabi M; Gomori A; Ethans K; Esfahani F; Galloway K; Namaka M
Pain Med; 2015 Jan; 16(1):149-59. PubMed ID: 25288189
[TBL] [Abstract][Full Text] [Related]
6. Analgesic and antihyperalgesic effects of nabilone on experimental heat pain.
Redmond WJ; Goffaux P; Potvin S; Marchand S
Curr Med Res Opin; 2008 Apr; 24(4):1017-24. PubMed ID: 18302810
[TBL] [Abstract][Full Text] [Related]
7. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study.
Vaney C; Heinzel-Gutenbrunner M; Jobin P; Tschopp F; Gattlen B; Hagen U; Schnelle M; Reif M
Mult Scler; 2004 Aug; 10(4):417-24. PubMed ID: 15327040
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury.
Pooyania S; Ethans K; Szturm T; Casey A; Perry D
Arch Phys Med Rehabil; 2010 May; 91(5):703-7. PubMed ID: 20434606
[TBL] [Abstract][Full Text] [Related]
10. An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.
Toth C; Mawani S; Brady S; Chan C; Liu C; Mehina E; Garven A; Bestard J; Korngut L
Pain; 2012 Oct; 153(10):2073-2082. PubMed ID: 22921260
[TBL] [Abstract][Full Text] [Related]
11. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
Karst M; Salim K; Burstein S; Conrad I; Hoy L; Schneider U
JAMA; 2003 Oct; 290(13):1757-62. PubMed ID: 14519710
[TBL] [Abstract][Full Text] [Related]
12. Nabilone for the Management of Pain.
Tsang CC; Giudice MG
Pharmacotherapy; 2016 Mar; 36(3):273-86. PubMed ID: 26923810
[TBL] [Abstract][Full Text] [Related]
13. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
[TBL] [Abstract][Full Text] [Related]
14. The effect of nabilone on neuropsychological functions related to driving ability: an extended case series.
Kurzthaler I; Bodner T; Kemmler G; Entner T; Wissel J; Berger T; Fleischhacker WW
Hum Psychopharmacol; 2005 Jun; 20(4):291-3. PubMed ID: 15834843
[TBL] [Abstract][Full Text] [Related]
15. Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial.
Côté M; Trudel M; Wang C; Fortin A
Ann Otol Rhinol Laryngol; 2016 Apr; 125(4):317-24. PubMed ID: 26503964
[TBL] [Abstract][Full Text] [Related]
16. Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Lorente Fernández L; Monte Boquet E; Pérez-Miralles F; Gil Gómez I; Escutia Roig M; Boscá Blasco I; Poveda Andrés JL; Casanova-Estruch B
Neurologia; 2014 Jun; 29(5):257-60. PubMed ID: 24035293
[TBL] [Abstract][Full Text] [Related]
17. Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis.
van Amerongen G; Kanhai K; Baakman AC; Heuberger J; Klaassen E; Beumer TL; Strijers RLM; Killestein J; van Gerven J; Cohen A; Groeneveld GJ
Clin Ther; 2018 Sep; 40(9):1467-1482. PubMed ID: 28189366
[TBL] [Abstract][Full Text] [Related]
18. Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.
Frank B; Serpell MG; Hughes J; Matthews JN; Kapur D
BMJ; 2008 Jan; 336(7637):199-201. PubMed ID: 18182416
[TBL] [Abstract][Full Text] [Related]
19. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
Bedi G; Cooper ZD; Haney M
Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
[TBL] [Abstract][Full Text] [Related]
20. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial.
Pini LA; Guerzoni S; Cainazzo MM; Ferrari A; Sarchielli P; Tiraferri I; Ciccarese M; Zappaterra M
J Headache Pain; 2012 Nov; 13(8):677-84. PubMed ID: 23070400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
